Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy.

N SaraiyaA C YoppN E RichM OdewoleNeehar D Parikh Amit G Singal

Published in: Alimentary pharmacology & therapeutics (2018)

Current data suggest acceptable HCC recurrence rates after DAA therapy, particularly if DAA therapy is delayed at least 6 months after HCC complete response. However, data characterising HCC recurrence after DAA therapy are of limited quality, highlighting the need for high quality prospective studies.

Keyphrases

electronic health record

deep learning

bone marrow

data analysis